Clinical Trial Update: Natural History Study of Patients With Excess Androgen

View source ↗

Summary

A NICHD-sponsored natural history study examining excess androgen in congenital adrenal hyperplasia and familial male-limited precocious puberty is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia
• Familial Male-limited Precocious Puberty

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Congenital Adrenal Hyperplasia (CAH), Familial Male-Limited Precocious Puberty (FMPP) | Status: RECRUITING